HYBRID EVENT: You can participate in person at Germany or Virtually from your home or work.

COPD 2022

Jordan B Minov, Speaker at Pulmonology Congress 2022
Keynote Presentation
Jordan B Minov, Institute for Occupational Health, North Macedonia

Occupational exposures may cause new-onset asthma in a healthy subject, aggravate pre-existing asthma in a symptomatic individual or reactivate asthma in an asymptomatic individual. All these disorders are covered by the term work-related asthma (WRA) or work-attributable asthma, [....] » Read More

Zhirong Zhang, Speaker at COPD Conference 2022
Oral Presentation
Zhirong Zhang, Université de Strasbourg, France

Inflammasome complexes are pivotal in the innate immune response to pathogens and other danger signals. The NLRP3 inflammasome is activated in response to a broad variety of cellular stressors, including COVID-19 infection. Most of the stimuli act in a potassium efflux-dependent [....] » Read More

Tatyana Sarycheva, Speaker at COPD-2022
Oral Presentation
Tatyana Sarycheva, Masaryk University, Czech Republic

Background: Impaired lung function has been established as an independent predictor of mortality but there is less evidence on the mortality risk in persons with preserved lung function. We assessed the pattern of all-cause and cardiovascular mortality across the full distributio [....] » Read More

Judith Coppinger, Speaker at COPD 2022 Confereces
Oral Presentation
Judith Coppinger, Royal College of Surgeons in Ireland, Ireland

Cystic Fibrosis and chronic obstructive pulmonary disease (COPD) are chronic lung disease characterized by progressive reduced lung function, inflammation associated with underlying genetic defects in the CF transmembrane conductance regulator (CFTR) channel. In our studies, we h [....] » Read More

Tammie Fournier, Speaker at COPD congress 2022
Oral Presentation
Tammie Fournier, Allied Health, New Brunswick Community College, Canada

Globally, COPD impacts approximately 10% of the population and is the third leading cause of death. Pulmonary Rehabilitation (PR) is a gold standard intervention in the management of COPD developed to slow disease progression, reduce disabling symptoms, and overall improve the qu [....] » Read More

Robyn Palk, Speaker at COPD-2022 Congress
Oral Presentation
Robyn Palk, Allied Health, New Brunswick Community College, Canada

Globally, COPD impacts approximately 10% of the population and is the third leading cause of death. Pulmonary Rehabilitation (PR) is a gold standard intervention in the management of COPD developed to slow disease progression, reduce disabling symptoms, and overall improve the qu [....] » Read More

Lisa Curtis, Speaker at COPD-2022 Conferences
Oral Presentation
Lisa Curtis, Allied Health, New Brunswick Community College, Canada

Globally, COPD impacts approximately 10% of the population and is the third leading cause of death. Pulmonary Rehabilitation (PR) is a gold standard intervention in the management of COPD developed to slow disease progression, reduce disabling symptoms, and overall improve the qu [....] » Read More

Catarina Costa Boffino , Speaker at COPD 2022 Conferences
Oral Presentation
Catarina Costa Boffino , São Paulo Methodist University , Brazil

The postural imbalance is an extra-pulmonary condition, associated with Chronic Obstructive Pulmonary Disease (COPD). COPD affects older individuals and it is unclear whether balance abnormalities can be described as pathophysiological mechanism or aging. The present study aimed [....] » Read More

Jirakrit Leelarungrayub, Speaker at COPD 2022 Congress
Oral Presentation
Jirakrit Leelarungrayub, Chiang Mai University, Thailand

Chronic Obstructive Pulmonary Disease (COPD) is still the main problem of people around the world as in Thailand. Low quality of life with less exercise intolerance is a critical issue for rehabilitation. Therefore, the development of a simple device from folk materials for respi [....] » Read More

Shadi Hamoud, Speaker at COPD Congress-2022
Oral Presentation
Shadi Hamoud, Rambam Health Care Campus, Israel

Since DEC 2019 health authorities all over the world are in continuous combat against the Coronavirus disease 2019 (COVID-19) pandemic. The disaese was first described in Wuhan, China on DEC 2019, followed by rapid spread all over the world, and caused by the Coronovirus SARS-COV [....] » Read More

Jose Luis Izquierdo Garcia, Speaker at COPD 2022 Conferences
Oral Presentation
Jose Luis Izquierdo Garcia, Complutense University of Madrid. Multidisciplinary Institute, Spain

Nuclear Magnetic Resonance Spectroscopy (NMR)-based metabolomic analysis of biofluids provides a potential tool for understanding biochemical processes associated with respiratory diseases. However the translation of NMR-based metabolomics to a clinic environment has several limi [....] » Read More

Daniela Cardoso, Speaker at COPD Conferences 2022
Poster Presentation
Daniela Cardoso, CHUC, Portugal

Introduction: The classification and management of COPD are currently based on a patient-centric approach, emphasising the importance of symptoms and exacerbation history (GOLD-classes). Since COPD patients present hight individual heterogeneity, the treatable traits (TT) strateg [....] » Read More

Mariana Conde, Speaker at COPD Congress 2022
Poster Presentation
Mariana Conde, Centro Hospital of Trás-os-Montes and Alto Douro - Vila Real, Portugal

The COVID-19 pandemic registered its first case in Portugal in March 2020. Its repercussion on the functioning of respiratory rehabilitation services has been significant, bringing a new population of respiratory patients. We aimed to evaluate the characteristics and evolution [....] » Read More

Po Ching Huang, Speaker at COPD Conference
Poster Presentation
Po Ching Huang, National Cheng Kung University, Taiwan

Chronic obstructive pulmonary disease (COPD) is an irreversible lung disease and exercise intervention in pulmonary rehabilitation is one of the recommended interventions with the benefits of improving the exercise tolerance and the quality of life. Telerehabilitation has the rep [....] » Read More

George E Chaux, Speaker at COPD congress 2022
Keynote Presentation
George E Chaux, Cedars Sinai Medical Center, United States

My presentation will focus on the current state of advanced surgical therapies available to treat patients with advanced emphysema/COPD. I will discuss surgical treatment options including bronchoscopic lung volume reduction, surgical lung volume reduction and lung transplantatio [....] » Read More

Piotr kusnierczyk, Speaker at COPD congress 2022
Keynote Presentation
Piotr kusnierczyk, Polish Academy of Sciences, Poland

  Immune eradication of cancer cells is dependent on polymorphisms of HLA class I molecules and antigen-processing machinery (APM) components, of which endoplasmic reticulum aminopeptidases 1 and 2 (ERAP1 and ERAP2) are most genetically polymorphic. We compared the distri [....] » Read More

Gustavo Lionel Knop, Speaker at COPD 2022 Conferences
Keynote Presentation
Gustavo Lionel Knop, Mayo Clinic, United States

Despite Chronic obstructive pulmonary disease (COPD) is still a leading cause of morbidity and mortality in the world, during the last decade interstitial lung disease has overtaken COPD as the most common indication for lung transplantation (LTx)_. Patients with advanced stage o [....] » Read More

Guoqing John Chen, Speaker at COPD 2022 Congress
Keynote Presentation
Guoqing John Chen, University of Kansas Medical Center, United States

Chronic Obstructive Pulmonary Disease (COPD) is a growing public health problem in in US. Depression is a common mental health problem accompanied by a high degree of emotional distress and functional impairment. More than one third of patients with COPD experience comorbid depre [....] » Read More

Tszshan Ma, Speaker at COPD Conferences 2022
Oral Presentation
Tszshan Ma, Emory University, United States

RATIONALE: Risk of Chronic Obstructive Pulmonary Disease (COPD) and its disparities associated with air pollution exposures are less clear and warrant more evidence. OBJECTIVES: To examine the association between long-term exposure to air pollution and COPD incidence. METHO [....] » Read More

Siti Nur Fariza Nordin, Speaker at COPD-2022 Congress
Oral Presentation
Siti Nur Fariza Nordin, The Canberra Hospital, Australia

Background: There is a paucity of information regarding patients with COPD and hip fracture (HF), one of the most devastating diseases in the elderly. Objective: To explore in a large cohort of HF patients the prevalence of COPD, its clinical profile and impact on hospital out [....] » Read More

Liuhua Shi, Speaker at COPD Congress 2022
Oral Presentation
Liuhua Shi, Emory University, United States

RATIONALE: Risk of Chronic Obstructive Pulmonary Disease (COPD) and its disparities associated with air pollution exposures are less clear and warrant more evidence. OBJECTIVES: To examine the association between long-term exposure to air pollution and COPD incidence. METHO [....] » Read More

Hamid Mcheick, Speaker at COPD Congress
Oral Presentation
Hamid Mcheick, University of Quebec at Chicoutimi, Canada

Nowaday, ubiquitous health system is reshaping the research in the medical domain due to its potential to concurrently overcome the challenges encountered in the traditional healthcare systems. Prediction of exacerbation of Chronic Obstructive Pulmonary Disease (COPD) is consider [....] » Read More

Ram Prasad P L, Speaker at COPD 2022 Conferences
Oral Presentation
Ram Prasad P L, SRM medical college hospital and research centre, India

INTRODUCTION: The most common cause of acute exacerbation of chronic pulmonary obstructive disease (AECOPD) is respiratory tract infections. The trend of bacterial flora changes from time to time and place to place. This study was undertaken to find out the common causative organ [....] » Read More

Saber Soltani, Speaker at COPD 2022 Congress
Oral Presentation
Saber Soltani, Tehran University of Medical Sciences, Iran (Islamic Republic of)

Background: There are reports of ocular tropism due to respiratory viruses such as severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). Various studies have shown ocular manifestation in coronavirus disease-2019 (COVID-19) patients. We aimed to identify ophthalmic manife [....] » Read More

Watsapp